Shipra Arya, MD
Vascular Surgery · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
11 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Arya’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C152421 · Current
Licensed to practise in California · since 2017 · expires 2027-01-31 · The All-India Institute of Medical Sciences.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$65,561
Medicare paid this office $65,561 for 225 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of muscle and/or tissue, 20.0 sq cm or less | 27 | $9,451 | $128 |
| Removal of skin and tissue, 20.0 sq cm or less | 22 | $3,796 | $48 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,215 | $117 |
| New patient visit (45+ min) | 15 | $1,680 | $112 |
| Short return visit (20+ min) | 17 | $1,588 | $59 |
See all 16 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 27 | $9,451 | $128 |
| Removal of skin and tissue, 20.0 sq cm or less | 22 | $3,796 | $48 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,215 | $117 |
| New patient visit (45+ min) | 15 | $1,680 | $112 |
| Short return visit (20+ min) | 17 | $1,588 | $59 |
| Return visit (30+ min) | 15 | $1,464 | $81 |
| Short return visit (20+ min) | 23 | $1,428 | $57 |
| Ultrasound of both sides of head and neck blood flow | 31 | $1,125 | $33 |
| New patient visit (30+ min) | 16 | $1,025 | $64 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 35 | $974 | $28 |
| Ultrasound of leg arteries or artery grafts | 20 | $687 | $33 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 13 | $582 | $45 |
| Complete ultrasound study of arm and leg arteries | 21 | $461 | $18 |
| Ultrasound study of arm and leg arteries | 35 | $365 | $10 |
| Ultrasound of one leg arteries or artery grafts | 15 | $336 | $19 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 12 | $221 | $18 |
Procedures Medicare counted
| Leg revascularization (restoring blood flow) | 1-10 | None |
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
225 Original Medicare patients in 2024. Average age 74 · Under 65 11% · 85 and older 13% · Women 43% · Also on Medicaid 35% · Health risk score 3.19. Above the middle of the specialty; the typical vascular surgery clinician is at 2.33.
Conditions among them: High blood pressure 75% · Coronary heart disease 56% · Chronic kidney disease 53% · Diabetes 51% · Heart failure 42% · Atrial fibrillation 36% · Depression 27% · Stroke 22% · Cancer 20% · COPD 18% · Dementia 17%.
The office billed $856,414, Medicare allowed $85,133 and paid $65,561; for 801 services of 78 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 225 | 801 | 74 | 3.19 | $856,414 | $65,561 |
| 2023 | 76 | 573 | 75 | 3.16 | $296,462 | $53,886 |
| 2022 | 29 | 141 | 77 | 3.28 | $64,315 | $14,969 |
| 2021 | 80 | 463 | 75 | 3.22 | $199,394 | $45,721 |
| 2020 | 88 | 471 | 73 | 3.52 | $200,249 | $41,488 |
| 2019 | 83 | 631 | 75 | 3.30 | $176,074 | $43,555 |
| 2018 | 78 | 555 | 73 | 2.76 | $202,896 | $42,400 |
| 2017 | 73 | 84 | 74 | 2.88 | $66,290 | $9,766 |
| 2016 | 348 | 484 | 72 | 2.56 | $419,557 | $60,603 |
| 2015 | 296 | 496 | 71 | 2.62 | $571,332 | $66,258 |
| 2014 | 417 | 609 | 73 | 2.16 | $475,562 | $76,878 |
| 2013 | 95 | 140 | 69 | 2.42 | $115,796 | $18,304 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 26 | $25,568 | $136 |
| Removal of skin and tissue, 20.0 sq cm or less | 18 | $2,948 | $39 |
| Short return visit (20+ min) | 13 | $1,681 | $60 |
| New patient visit (45+ min) | 13 | $1,560 | $120 |
2022: 1 service
| Removal of skin and tissue, 20.0 sq cm or less | 11 | $767 | $45 |
2021: 6 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 28 | $15,003 | $135 |
| Management of oxygen chamber therapy | 13 | $7,350 | $97 |
| Removal of skin and tissue, 20.0 sq cm or less | 27 | $5,221 | $51 |
| New patient visit (45+ min) | 14 | $1,574 | $112 |
| Return visit (30+ min) | 13 | $1,268 | $91 |
| Short return visit (20+ min) | 17 | $959 | $53 |
2020: 6 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 23 | $8,288 | $136 |
| Removal of skin and tissue, 20.0 sq cm or less | 44 | $5,501 | $44 |
| Removal of bone, 20.0 sq cm or less | 12 | $4,785 | $208 |
| New patient visit (45+ min) | 23 | $2,483 | $108 |
| Short return visit (20+ min) | 18 | $1,101 | $44 |
| Return visit (30+ min) | 12 | $1,016 | $73 |
2019: 5 services
| Removal of skin and tissue, 20.0 sq cm or less | 48 | $12,633 | $52 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 18 | $10,349 | $134 |
| New patient visit (45+ min) | 16 | $1,763 | $110 |
| Short return visit (20+ min) | 22 | $1,015 | $44 |
| Return visit (30+ min) | 13 | $784 | $60 |
2018: 5 services
| Removal of skin and tissue, 20.0 sq cm or less | 46 | $12,939 | $53 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 21 | $10,658 | $137 |
| New patient visit (45+ min) | 22 | $2,423 | $110 |
| Short return visit (20+ min) | 12 | $684 | $46 |
| Short return visit | 18 | $518 | $23 |
2017: 1 service
| Ultrasound study of one arm or leg veins with compression and maneuvers | 12 | $842 | $70 |
2016: 11 services
| Ultrasound of both sides of head and neck blood flow | 88 | $13,739 | $148 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 39 | $5,625 | $144 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 32 | $4,724 | $148 |
| Ultrasound of leg arteries or artery grafts | 22 | $3,318 | $151 |
| Complete ultrasound study of arm and leg arteries | 34 | $3,311 | $97 |
| Ultrasound of one leg arteries or artery grafts | 27 | $3,282 | $109 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 16 | $3,167 | $167 |
| Ultrasound study of arm and leg arteries | 42 | $2,468 | $57 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 24 | $2,290 | $92 |
| New patient visit (45+ min) | 11 | $1,320 | $120 |
| Short return visit (20+ min) | 18 | $1,153 | $55 |
2015: 10 services
| Ultrasound of both sides of head and neck blood flow | 69 | $11,426 | $152 |
| Ultrasound study of arm and leg arteries | 88 | $5,640 | $61 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 37 | $5,538 | $142 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 47 | $4,462 | $93 |
| Ultrasound of hemodialysis access | 18 | $3,666 | $122 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 23 | $3,488 | $145 |
| Ultrasound of one leg arteries or artery grafts | 27 | $3,182 | $114 |
| Short return visit (20+ min) | 17 | $919 | $54 |
| Short return visit | 26 | $915 | $33 |
| New patient visit (30+ min) | 11 | $857 | $78 |
2014: 9 services
| Ultrasound of both sides of head and neck blood flow | 114 | $16,687 | $138 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 54 | $9,406 | $162 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 75 | $7,660 | $81 |
| Ultrasound study of arm and leg arteries | 106 | $6,856 | $59 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 42 | $6,115 | $142 |
| Ultrasound of one leg arteries or artery grafts | 25 | $2,832 | $105 |
| Ultrasound of leg arteries or artery grafts | 12 | $2,350 | $181 |
| Ultrasound of hemodialysis access | 12 | $1,311 | $101 |
| Short return visit (20+ min) | 17 | $1,150 | $55 |
2013: 4 services
| Ultrasound of both sides of head and neck blood flow | 15 | $2,077 | $138 |
| Ultrasound study of arm and leg arteries | 30 | $1,984 | $66 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 11 | $1,629 | $148 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 15 | $1,426 | $89 |
Drugs they prescribed that Part D paid
$4,127
Pharmacies billed $4,127 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 23) in 2024. Too few prescriptions to compare fairly with other clinicians.
20 generic and fewer than 11 brand-name prescriptions · $4,127 in drug cost · 19 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cephalexin | 11 | $62 | $6 |
Year by year
| 2024 | 23 | 16 | 0% (0) | None | $4,127 |
| 2023 | 15 | None | 0% (0) | None | $520 |
| 2021 | 11 | None | 0% (0) | None | $1,758 |
| 2020 | 24 | 18 | 0% (0) | None | $977 |
| 2019 | 29 | 17 | 0% (0) | None | $946 |
| 2018 | 34 | 23 | 0% (0) | None | $1,172 |
| 2017 | 13 | None | 0% (0) | None | $383 |
| 2016 | 59 | 20 | None | 20% | $1,945 |
| 2015 | 104 | 27 | 11% (11) | 11% | $1,492 |
| 2014 | 77 | 16 | 14% (11) | 18% | $1,401 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2018: 1 drug
| Amoxicillin-Clavulanate Potass | 12 | $164 | $14 |
2016: 2 drugs
| Atorvastatin | 24 | $454 | $19 |
| Clopidogrel | 13 | $389 | $30 |
2015: 4 drugs
| Atorvastatin | 25 | $460 | $18 |
| Clopidogrel | 18 | $311 | $17 |
| Sulfamethoxazole-Trimethoprim | 11 | $202 | $18 |
| Gabapentin | 20 | $119 | $6 |
2014: 1 drug
| Clopidogrel | 12 | $130 | $11 |
Money from drug and device companies
$372 in 2025
| 2025 | 2 | 5 | None | $372 |
| 2024 | 3 | 4 | None | $262 |
| 2023 | 2 | 7 | $1,710 | $2,124 |
| 2022 | 2 | 2 | None | $246 |
| 2021 | 1 | 1 | None | $97 |
| 2019 | 3 | 4 | None | $328 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| W. L. Gore & Associates | Gore Excluder Aaa Endoprosthesis | $355 | 4 payments
|
| Boston Scientific | Enroute Transcarotid Neuroprotection System | $17 | 1 payment
|
See all 5 published payments
| Boston Scientific | Meals · 2025-12-03 | Enroute Transcarotid Neuroprotection System | $17 |
| W. L. Gore & Associates | Meals · 2025-11-20 | Gore Tag Thoracic Branch Endoprosthesis | $155 |
| W. L. Gore & Associates | Meals · 2025-10-11 | Gore Viabahn Vbx Balloon Expandable Endo | $27 |
| W. L. Gore & Associates | Meals · 2025-09-16 | Gore Excluder Aaa Endoprosthesis | $157 |
| W. L. Gore & Associates | Meals · 2025-03-28 | Gore Viabahn Vbx Balloon Expandable Endo | $16 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $262
| Penumbra | Indigo System | $185 | 1 payment
|
| Ethicon US | Stratafix | $45 | 1 payment
|
| Cook Medical | Zenith | $32 | 2 payments
|
2023: $2,124
| W. L. Gore & Associates | Gore Tag Thoracic Branch Endoprosthesis | $1,976 | 6 payments
|
| Bolton Medical | Relay Thoracic Stent-Graft With Plus Delivery System | $148 | 1 payment
|
2022: $246
| W. L. Gore & Associates | Gore Tag Conformable Thoracic Endoprosthesis | $159 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $88 | 1 payment
|
2021: $97
| W. L. Gore & Associates | Excluder Conformable Aaa Endoprosthesis With Active Control | $97 | 1 payment
|
2019: $328
| Cook Medical | None | $167 | 2 payments
|
| Acell | None | $94 | 1 payment
|
| Silk Road Medical | Enroute Transcarotid Neuroprotection System | $67 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1952517476
- Licence
- CA C152421California C152421: Current · expires 2027-01-31
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2086S0129X (2086S0129X); Federal specialty code 2083P0011X (2083P0011X); Surgery (208600000X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94304
- NPI first listed
- 2007-05-14
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr Rm M121, Stanford, CA, 94305